# The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

> **NCT02523495** · — · UNKNOWN · sponsor: **Huazhong University of Science and Technology** · enrollment: 120 (estimated)

## Conditions studied

- Neoplasms, Therapy-Associated

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02523495
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2020-07
- **Final completion:** 2022-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02523495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02523495, "The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02523495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*